Association of MMP - 12 polymorphisms with severe and very severe COPD: A case control study of MMPs - 1, 9 and 12in a European population
Open Access
- 15 January 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Genetics
- Vol. 11 (1), 7
- https://doi.org/10.1186/1471-2350-11-7
Abstract
Genetic factors play a role in chronic obstructive pulmonary disease (COPD) but are poorly understood. A number of candidate genes have been proposed on the basis of the pathogenesis of COPD. These include the matrix metalloproteinase (MMP) genes which play a role in tissue remodelling and fit in with the protease - antiprotease imbalance theory for the cause of COPD. Previous genetic studies of MMPs in COPD have had inadequate coverage of the genes, and have reported conflicting associations of both single nucleotide polymorphisms (SNPs) and SNP haplotypes, plausibly due to under-powered studies. To address these issues we genotyped 26 SNPs, providing comprehensive coverage of reported SNP variation, in MMPs- 1, 9 and 12 from 977 COPD patients and 876 non-diseased smokers of European descent and evaluated their association with disease singly and in haplotype combinations. We used logistic regression to adjust for age, gender, centre and smoking history. Haplotypes of two SNPs in MMP-12 (rs652438 and rs2276109), showed an association with severe/very severe disease, corresponding to GOLD Stages III and IV. Those with the common A-A haplotype for these two SNPs were at greater risk of developing severe/very severe disease (p = 0.0039) while possession of the minor G variants at either SNP locus had a protective effect (adjusted odds ratio of 0.76; 95% CI 0.61 - 0.94). The A-A haplotype was also associated with significantly lower predicted FEV1 (42.62% versus 44.79%; p = 0.0129). This implicates haplotypes of MMP-12 as modifiers of disease severity.Keywords
This publication has 35 references indexed in Scilit:
- A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility LociPLoS Genetics, 2009
- Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPDEuropean Respiratory Journal, 2008
- Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPDRespiratory Research, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritizationNucleic Acids Research, 2006
- The SERPINE2 Gene and Chronic Obstructive Pulmonary DiseaseAmerican Journal of Human Genetics, 2006
- Definition, epidemiology, and risk factorsBMJ, 2006
- Elevated MMP-12 protein levels in induced sputum from patients with COPDThorax, 2006
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Genetic Polymorphism in Matrix Metalloproteinase-9 and Pulmonary EmphysemaBiochemical and Biophysical Research Communications, 2001